| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Technology Officer | Chief Technology Officer
1 company
Hanly Ann M. is an EVP &Chief Technology Officer at Vir Biotechnology, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | EVP &Chief Technology Officer | Sell | 14,168 | $9.45 | $133,935.77 | -10.7% | -50.8% | +0.2% | |
| Apr 1, 2024 | VIR Vir Biotechnology, Inc. | EVP &Chief Technology Officer | Sell | 2,711 | $10.05 | $27,250.97 | -2.0% | -10.8% | -39.4% | |
| Feb 22, 2024 | VIR Vir Biotechnology, Inc. | EVP &Chief Technology Officer | Sell | 12,296 | $10.05 | $123,520.70 | -8.4% | +10.4% | -7.1% | |
| Mar 30, 2023 | VIR Vir Biotechnology, Inc. | Chief Technology Officer | Sell | 2,627 | $22.77 | $59,816.79 | -2.2% | +8.2% | -56.0% | |
| Feb 23, 2023 | VIR Vir Biotechnology, Inc. | Chief Technology Officer | Sell | 2,302 | $25.97 | $59,789.85 | -1.9% | +1.1% | -55.3% | |
| Mar 30, 2022 | VIR Vir Biotechnology, Inc. | Chief Technology Officer | Sell | 2,627 | $26.24 | $68,925.39 | -3.1% | -0.7% | -11.2% | |
| Nov 29, 2021 | VIR Vir Biotechnology, Inc. | Chief Technology Officer | Buy | 12 | $43.39 | $499.85 | New | -37.8% | -32.7% |